{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:58:58Z","timestamp":1771660738455,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3C1631"],"award-info":[{"award-number":["CMRPG3C1631"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["3C1632"],"award-info":[{"award-number":["3C1632"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["3C1633"],"award-info":[{"award-number":["3C1633"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.cca.2016.07.013","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T18:57:32Z","timestamp":1469127452000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Increased serum concentrations of transforming growth factor-\u03b21 (TGF-\u03b21) in patients with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"461","author":[{"given":"Kuo-Hsuan","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Kuo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Shi","family":"Ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Sun","family":"Ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Shiu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Feng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Chou","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Che","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2016.07.013_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.07.013_bb0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/WCO.0b013e328357a77f","article-title":"Autoantibodies in immune-mediated neuropathies","volume":"25","author":"Chavada","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/glycob\/cwp027","article-title":"Antiganglioside antibodies and their pathophysiological effects on Guillain\u2013Barr\u00e9 syndrome and related disorders\u2014a review","volume":"19","author":"Kaida","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.cca.2016.07.013_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1468-1331.2007.01761.x","article-title":"Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients","volume":"14","author":"Jin","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/prca.200600949","article-title":"Elevated haptoglobin level of cerebrospinal fluid in Guillain-Barr\u00e9 syndrome revealed by proteomics analysis","volume":"1","author":"Chang","year":"2007","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.cca.2016.07.013_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0404.2011.01511.x","article-title":"Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"125","author":"Zhang","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cca.2016.07.013_bb0040","doi-asserted-by":"crossref","first-page":"639712","DOI":"10.1155\/2013\/639712","article-title":"Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barr\u00e9 syndrome","volume":"2013","author":"Li","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2016.07.013_bb0045","doi-asserted-by":"crossref","first-page":"740947","DOI":"10.1155\/2014\/740947","article-title":"Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barr\u00e9 syndrome and downregulated by IVIg treatments","volume":"2014","author":"Li","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2016.07.013_bb0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0165-5728(00)00460-4","article-title":"Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy","volume":"114","author":"Jander","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0055","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1172\/JCI113231","article-title":"Activation of terminal components of complement in patients with Guillain-Barr\u00e9 syndrome and other demyelinating neuropathies","volume":"80","author":"Koski","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2016.07.013_bb0060","article-title":"Identification of gene networks and pathways associated with Guillain-Barr\u00e9 syndrome","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.07.013_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.07.013_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/120.3.451","article-title":"Central nervous system pathology in patients with the Guillain-Barr\u00e9 syndrome","volume":"120","author":"Maier","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.cca.2016.07.013_bb0075","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome","volume":"27","author":"Hartung","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-3-11","article-title":"Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1\u03b1 by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats","volume":"3","author":"Hofmann","year":"2002","journal-title":"BMC Immunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2016.07.013_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","article-title":"Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"29","author":"Van den Bergh","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2016.07.013_bb0100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/WNL.37.9.1493","article-title":"Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings","volume":"37","author":"Fross","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.07.013_bb0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0110","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.07.013_bb0115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2016.07.013_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0404.2002.01301.x","article-title":"Increased plasma TGF-\u03b21 in patients with amyotrophic lateral sclerosis","volume":"106","author":"Houi","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cca.2016.07.013_bb0130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0531-5565(02)00018-9","article-title":"Decrease of TGF-\u03b21 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease","volume":"37","author":"De Servi","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.cca.2016.07.013_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10072-006-0562-6","article-title":"Increased intrathecal TGF-\u03b21, but not IL-12, IFN-\u03b3 and IL-10 levels in Alzheimer's disease patients","volume":"27","author":"Rota","year":"2006","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.cca.2016.07.013_bb0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jnnp.64.2.162","article-title":"Circulating transforming growth factor beta 1 (TGF- \u03b21) in Guillain-Barr\u00e9 syndrome: decreased concentrations in the early course and increase with motor function","volume":"64","author":"Creange","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2016.07.013_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1468-1331.2000.00005.x","article-title":"Expression of TNF\u03b1 and TGF\u03b21 in Guillain-Barr\u00e9 syndrome: correlation of a low TNF\u03b1-\/TGF\u03b21-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment","volume":"7","author":"Ossege","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0150","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1600-0463.2003.apm1111204.x","article-title":"Elevated number of cells secreting transforming growth factor beta in Guillain-Barr\u00e9 syndrome","volume":"111","author":"Dahle","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.cca.2016.07.013_bb0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri2095","article-title":"TGF\u03b2 signalling in control of T-cell-mediated self-reactivity","volume":"7","author":"Rubtsov","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0160","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.4049\/jimmunol.170.11.5563","article-title":"Uncoupling of promitogenic and antiapoptotic functions of IL-2 by smad-dependent TGF-\u03b2 signaling","volume":"170","author":"Nelson","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.189.2.231","article-title":"Transforming growth factor \u03b21 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc","volume":"189","author":"Genestier","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2016.07.013_bb0170","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.144.5.1767","article-title":"Regulatory effects of transforming growth factor-\u03b2 on IL-2- and IL-4-dependent T cell-cycle progression","volume":"144","author":"Ruegemer","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0175","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.4049\/jimmunol.173.5.3093","article-title":"p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-\u03b2-mediated G1 arrest through modulation of IL-2 responsiveness","volume":"173","author":"Wolfraim","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0180","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.20012076","article-title":"Mechanism of transforming growth factor \u03b2-induced inhibition of T helper type 1 differentiation","volume":"195","author":"Gorelik","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2016.07.013_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/mcne.1999.0771","article-title":"Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-\u03b21 gene expression during remyelination of experimentally-induced spinal cord demyelination","volume":"14","author":"Hinks","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.cca.2016.07.013_bb0190","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.1999.17.2.607","article-title":"Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma","volume":"17","author":"Maehara","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2016.07.013_bb0195","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2014-03-537506","article-title":"Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas","volume":"123","author":"Graus","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cca.2016.07.013_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-5728(93)90284-6","article-title":"Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"47","author":"Maimone","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2016.07.013_bb0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-510X(96)00319-X","article-title":"Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP","volume":"147","author":"Sivieri","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cca.2016.07.013_bb0210","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.07.013_bb0215","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2016.07.013_bb0220","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1309\/AJCP7UBK8IBVMVNR","article-title":"Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay","volume":"136","author":"Martins","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2016.07.013_bb0225","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1155\/2013\/567162","article-title":"New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging","volume":"34","author":"Palavra","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cca.2016.07.013_bb0230","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.07.013_bb0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cca.2016.07.013_bb0240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cca.2016.07.013_bb0245","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.wnl.0000344569.13496.ff","article-title":"Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies","volume":"72","author":"Nobile-Orazio","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.cca.2016.07.013_bb0250","doi-asserted-by":"crossref","first-page":"564098","DOI":"10.1155\/2015\/564098","article-title":"Biomarkers of Guillain-Barr\u00e9 syndrome: some recent progress, more still to be explored","volume":"2015","author":"Wang","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2016.07.013_bb0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0404.2003.00179.x","article-title":"Serum tumour necrosis factor-\u03b1 and soluble tumour necrosis factor receptors levels in patients with Guillain-Barr\u00e9 syndrome","volume":"109","author":"Radhakrishnan","year":"2004","journal-title":"Acta Neurol. Scand."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116303138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116303138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T09:03:34Z","timestamp":1692435814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898116303138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":51,"alternative-id":["S0009898116303138"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2016.07.013","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum concentrations of transforming growth factor-\u03b21 (TGF-\u03b21) in patients with Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2016.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}